Stockreport

CTSO: CytoSorbents Announces Submission of DrugSorb-ATR Application to the FDA [Yahoo! Finance]

Cytosorbents Corporation  (CTSO) 
Last cytosorbents corporation earnings: 11/5 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: cytosorbents.com
PDF On October 1, 2024, CytoSorbents (NASDAQ:CTSO) announced the submission of its DrugSorb-ATR medical device De Novo marketing application to the U.S. Food and Drug Admin [Read more]